Fetal gene therapy for neurodegenerative lysosomal storage diseases
J Inherit Metab Dis
.
2019 May;42(3):391-393.
doi: 10.1002/jimd.12018.
Epub 2019 Feb 4.
Authors
Julien Baruteau
1
2
3
,
Simon N Waddington
1
4
Affiliations
1
Gene Transfer Technology Group, Institute for Women's Health, University College London, London, UK.
2
Metabolic Medicine Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
3
Genetics and Genomic Medicine Programme, Great Ormond Street Institute of Child Health, University College London, London, UK.
4
Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
PMID:
30715735
DOI:
10.1002/jimd.12018
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Animals
Disease Models, Animal
Fetal Therapies*
Genetic Therapy*
Humans
Lysosomal Storage Diseases / therapy*
Stem Cell Transplantation*
Grants and funding
MR/N026101/1/MRC_/Medical Research Council/United Kingdom
MR/R015325/1/MRC_/Medical Research Council/United Kingdom
DH_/Department of Health/United Kingdom
MR/P026494/1/MRC_/Medical Research Council/United Kingdom
MR/N019075/1/MRC_/Medical Research Council/United Kingdom